Time spent outdoors is the best defence against rising rates of short-sightedness, but scientists are searching for other ways to reverse the troubling trend.By Elie Dolgin A physician examines the eyesight of a child with myopia in Hebei province, northern China. Credit: Sipa US/Alamy The COVID-19 pandemic didn’t just reshape how children learn and see...
Patients in primary care clinic program lost 5 percent of body weight PENNINGTON BIOMEDICAL RESEARCH CENTER BATON ROUGE, Louisiana – Low-income Louisiana patients enrolled in a tailored obesity intervention program lost much more weight than counterparts receiving usual care. Study results were published this week in The New England Journal of Medicine. This population, who...
Dry air could prompt further disease spread A study focused on the Greater Sydney area during the early epidemic stage of COVID-19 found an association between lower humidity and an increase in community transmission. Now a second study by the same team confirms the risk. The study is published today in Transboundary and Emerging Diseases....
by Eric Hamilton, University of Wisconsin-Madison University of Wisconsin-Madison scientists have discovered that a majority of back-pain patients they tested who were taking opioid painkillers produced anti-opioid antibodies. These antibodies may contribute to some of the negative side effects of long-term opioid use. Existing antibodies may also limit the benefit a patient receives from an...
12 August 2020, 6:51 am EDT By CJ Robles Tech Times Bill Gates has been super vocal about how the United States has been handling the coronavirus pandemic. With more than 5 million confirmed cases in the U.S., the Microsoft co-founder has been making calls for the government and businessmen alike to ensure that everyone...
So far there are no approved drugs for Non-Alcoholic Fatty Liver Disease UNIVERSITY OF COLORADO ANSCHUTZ MEDICAL CAMPUS AURORA, Colo. (July 8, 2020) – In an effort to combat a growing worldwide epidemic of Nonalcoholic Fatty Liver Disease (NAFLD), scientists have discovered a new target and a new therapy that has shown promising results in...
Researchers have shown that a variation in the viral genome of Covid-19 improved its ability to infect human cells and helped it become the dominant strain circulating around the world today. The study, published today in the journal Cell, shows the variation is more infectious in cell cultures under laboratory conditions. The variant, named ‘D614G’,...
The neutralizing antibody, called S309, is on an accelerated path toward clinical trials. An antibody first identified in a blood sample from a patient who recovered from Severe Acute Respiratory Syndrome in 2003 inhibits related coronaviruses, including the cause of COVID-19. The antibody, called S309, is now on a fast-track development and testing path at...
by Durland Fish, The Conversation In the 1970s, an epidemic of mysterious arthritis-like symptoms began spreading among children in the lushly wooded area around Lyme, Connecticut. Scientists traced the cause to tick bites and named it Lyme disease, but why it had suddenly appeared there was a mystery. Similar symptoms had been documented on Long...
By ELIZABETH COONEY Before Wednesday’s hopeful news about the experimental antiviral remdesivir broke, doctors treating patients hospitalized for Covid-19 were already hearing from a few families desperate to get the drug for their loved ones. Now they expect to hear more pleas in the days to come, even though the data are preliminary, results are...
